SCHEMBL20149158

SCHEMBL20149158

CCCC(C)Oc1ccc(N)c(F)c1F

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 3/20 0.44
ALDH1A1 P00352 3/20 0.33
POLB P06746 3/20 0.33
KDM4E B2RXH2 2/20 0.33
MEN1 O00255 2/20 0.33
MAPT P10636 2/20 0.33
KMT2A Q03164 2/20 0.33
HPGD P15428 1/20 0.33
MAPK1 P28482 1/20 0.33
HSD17B10 Q99714 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
DHODH Q02127 5/20 0.32
SLC2A1 P11166 1/20 0.31
USP2 O75604 1/20 0.30
TP53 P04637 1/20 0.30
GAA P10253 1/20 0.30
CASP1 P29466 1/20 0.30
HTT P42858 1/20 0.30
CASP7 P55210 1/20 0.30
ATM Q13315 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17048355 0.78 POLB (0.37) MCHR1ALDH1A1POLBKDM4EMEN1
SCHEMBL20226508 0.77 MCHR1 (0.41) MCHR1DHODH
SCHEMBL1341433 0.74 MCHR1 (0.55) MCHR1ALDH1A1KDM4EMAPTGAA
SCHEMBL7736641 0.72 MAPT (0.53) ALDH1A1POLBKDM4EMEN1MAPT
SCHEMBL30126872 0.72 KDM4E (0.32) KDM4EMEN1MAPTKMT2AGAA
SCHEMBL20226625 0.72 MCHR1 (0.38) MCHR1ALDH1A1MEN1KMT2ADHODH
SCHEMBL20226560 0.72 MCHR1 (0.35) MCHR1
SCHEMBL15120816 0.72 MCHR1 (0.33) MCHR1
SCHEMBL17366254 0.70 MCHR1 (0.48) MCHR1ALDH1A1HPGDL3MBTL1DHODH
SCHEMBL11838849 0.70 MCHR1 (0.54) MCHR1ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11760775-B2 Steroids and protein-conjugates thereof REGENERON PHARMACEUTICALS, INC. 2023-09-19 US disclosed
US-20210040144-A1 STEROIDS AND PROTEIN-CONJUGATES THEREOF REGENERON PHARMACEUTICALS, INC. 2021-02-11 US disclosed
US-10711032-B2 Steroids and protein-conjugates thereof REGENERON PHARMACEUTICALS, INC. (US) 2020-07-14 US disclosed
WO-2018089373-A9 STEROIDS AND PROTEIN-CONJUGATES THEREOF REGENERON PHARMACEUTICALS, INC. (US) 2018-07-12 WO disclosed
US-20180155389-A1 STEROIDS AND PROTEIN-CONJUGATES THEREOF REGENERON PHARMACEUTICALS, INC. 2018-06-07 US disclosed
WO-2018089373-A2 STEROIDS AND PROTEIN-CONJUGATES THEREOF REGENERON PHARMACEUTICALS, INC. (US) 2018-05-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180155389-A1 STEROIDS AND PROTEIN-CONJUGATES THEREOF SERPINA6, NR3C1, NR3C2 MCHR1 1711/4885ALDH1A1 4143/4885POLB 4101/4885
US-10711032-B2 Steroids and protein-conjugates thereof SERPINA6, NR3C1, NR3C2 MCHR1 1711/4885ALDH1A1 4143/4885POLB 4101/4885
US-20210040144-A1 STEROIDS AND PROTEIN-CONJUGATES THEREOF SERPINA6, NR3C1, NR3C2 MCHR1 1775/4885ALDH1A1 4113/4885POLB 4154/4885
US-11760775-B2 Steroids and protein-conjugates thereof SERPINA6, NR3C1, NR3C2 MCHR1 1775/4885ALDH1A1 4113/4885POLB 4154/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.